Franca Cambi

Chen, K., Cambi, F., & Kozai, T.D.Y. (2023). Pro-myelinating Clemastine administration improves recording performance of chronically implanted microelectrodes and nearby neuronal health. bioRxiv.Cold Spring Harbor Laboratory. doi: 10.1101/2023.01.31.526463.

Klimas, A., Gallagher, B.R., Wijesekara, P., Fekir, S., DiBernardo, E.F., Cheng, Z., Stolz, D.B., Cambi, F., Watkins, S.C., Brody, S.L., Horani, A., Barth, A.L., Moore, C.I., Ren, X., & Zhao, Y. (2023). Magnify is a universal molecular anchoring strategy for expansion microscopy. NATURE BIOTECHNOLOGY, 41(6), 858-+.Springer Science and Business Media LLC. doi: 10.1038/s41587-022-01546-1.

Song, S., Hasan, M.N., Yu, L., Paruchuri, S.S., Bielanin, J.P., Metwally, S., Oft, H.C.M., Fischer, S.G., Fiesler, V.M., Sen, T., Gupta, R.K., Foley, L.M., Hitchens, T.K., Dixon, C.E., Cambi, F., Sen, N., & Sun, D. (2022). Microglial-oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury. JOURNAL OF NEUROINFLAMMATION, 19(1), 246.Springer Science and Business Media LLC. doi: 10.1186/s12974-022-02608-6.

Dubaniewicz, M., Eles, J.R., Lam, S., Song, S., Cambi, F., Sun, D., Wellman, S.M., & Kozai, T.D.Y. (2021). Inhibition of Na⁺/H⁺ exchanger modulates microglial activation and scar formation following microelectrode implantation. JOURNAL OF NEURAL ENGINEERING, 18(4), 045001.IOP Publishing. doi: 10.1088/1741-2552/abe8f1.

Zhang, S., Wang, Y., Zhu, X., Song, L., Zhan, X., Ma, E., McDonough, J., Fu, H., Cambi, F., Grinspan, J., & Guo, F. (2021). The Wnt Effector TCF7l2 Promotes Oligodendroglial Differentiation by Repressing Autocrine BMP4-Mediated Signaling. JOURNAL OF NEUROSCIENCE, 41(8), 1650-1664.Society for Neuroscience. doi: 10.1523/JNEUROSCI.2386-20.2021.

Guzman, K.M., Brink, L.E., Rodriguez-Bey, G., Bodnar, R.J., Kuang, L., Xing, B., Sullivan, M., Park, H.J., Koppes, E., Zhu, H., Padiath, Q., & Cambi, F. (2020). Conditional depletion of Fus in oligodendrocytes leads to motor hyperactivity and increased myelin deposition associated with Akt and cholesterol activation. GLIA, 68(10), 2040-2056.Wiley. doi: 10.1002/glia.23825.

Su, X.W., Palka, S.V., Rao, R.R., Chen, F.S., Brackney, C.R., & Cambi, F. (2020). SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia. MUSCLE & NERVE, 62(2), E48-E49.Wiley. doi: 10.1002/mus.26988.

Wellman, S.M., Guzman, K., Stieger, K.C., Brink, L.E., Sridhar, S., Dubaniewicz, M.T., Li, L., Cambi, F., & Kozai, T.D.Y. (2020). Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces. BIOMATERIALS, 239, 119842.Elsevier BV. doi: 10.1016/j.biomaterials.2020.119842.

Espay, A.J., Vizcarra, J.A., Marsili, L., Lang, A.E., Simon, D.K., Merola, A., Josephs, K.A., Fasano, A., Morgante, F., Savica, R., Greenamyre, J.T., Cambi, F., Yamasaki, T.R., Tanner, C.M., Gan-Or, Z., Litvan, I., Mata, I.F., Zabetian, C.P., Brundin, P., Fernandez, H.H., Standaert, D.G., Kauffman, M.A., Schwarzschild, M.A., Sardi, S.P., Sherer, T., Perry, G., & Leverenz, J.B. (2019). Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. NEUROLOGY, 92(7), 329-337.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.0000000000006926.

Wellman, S.M., Cambi, F., & Kozai, T.D.Y. (2018). The role of oligodendrocytes and their progenitors on neural interface technology: A novel perspective on tissue regeneration and repair. BIOMATERIALS, 183, 200-217.Elsevier BV. doi: 10.1016/j.biomaterials.2018.08.046.

Xing, B., Brink, L.E., Maers, K., Sullivan, M.L., Bodnar, R.J., Stolz, D.B., & Cambi, F. (2018). Conditional depletion of GSK3b protects oligodendrocytes from apoptosis and lessens demyelination in the acute cuprizone model. GLIA, 66(9), 1999-2012.Wiley. doi: 10.1002/glia.23453.

Leehey, M., Luo, S., Sharma, S., Wills, A.M.A., Bainbridge, J.L., Wong, P.S., Simon, D.K., Schneider, J., Zhang, Y., Perez, A., Dhall, R., Christine, C.W., Singer, C., Cambi, F., & Boyd, J.T. (2017). Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. NEUROLOGY, 89(17), 1789-1794.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.0000000000004572.

Kapeli, K., Pratt, G.A., Vu, A.Q., Hutt, K.R., Martinez, F.J., Sundararaman, B., Batra, R., Freese, P., Lambert, N.J., Huelga, S.C., Chun, S.J., Liang, T.Y., Chang, J., Donohue, J.P., Shiue, L., Zhang, J., Zhu, H., Cambi, F., Kasarskis, E., Hoon, S., Jr, A.M., Burge, C.B., Ravits, J., Rigo, F., & Yeo, G.W. (2016). Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. NATURE COMMUNICATIONS, 7(1), 12143.Springer Science and Business Media LLC. doi: 10.1038/ncomms12143.

Schneider, J.S., Cambi, F., Gollomp, S.M., Kuwabara, H., Brasic, J.R., Leiby, B., Sendek, S., & Wong, D.F. (2015). GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding. JOURNAL OF THE NEUROLOGICAL SCIENCES, 356(1-2), 118-123.Elsevier BV. doi: 10.1016/j.jns.2015.06.028.

Simuni, T., Kieburtz, K., Tilley, B., Elm, J.J., Ravina, B., Babcock, D., Emborg, M., Hauser, R., Kamp, C., Morgan, J.C., Ross, G.W., Simon, D.K., Bainbridge, J., Baker, L., Bodis-Wollner, I., Boyd, J., Cambi, F., Carter, J., Chou, K., Dahodwala, N., Jr, D.R.B., Dhall, R., Fang, J., Farrow, B., Feigin, A., Glazman, S., Goudreau, J., LeBlanc, P., Lee, S., Leehey, M., Lew, M.F., Lowenhaupt, S., Luo, S., Pahwa, R., Perez, A., Schneider, J., Scott, B., Shah, B., Shannon, K.M., Sharma, S., Singer, C., Truong, D., Wagner, R., Williams, K., Wills, A.M., Wong, P.S., Zadikoff, C., Zweig, R., & Parkinson, N.E.T. (2015). Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. LANCET NEUROLOGY, 14(8), 795-803.Elsevier BV. doi: 10.1016/S1474-4422(15)00144-1.

Elm, J.J., & NINDS NET-PD Investigators. (2012). Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord, 27(12), 1513-1521.Wiley. doi: 10.1002/mds.25175.

Goldman, S.M., Quinlan, P.J., Ross, G.W., Marras, C., Meng, C., Bhudhikanok, G.S., Comyns, K., Korell, M., Chade, A.R., Kasten, M., Priestley, B., Chou, K.L., Fernandez, H.H., Cambi, F., Langston, J.W., & Tanner, C.M. (2012). Solvent exposures and parkinson disease risk in twins. ANNALS OF NEUROLOGY, 71(6), 776-784.Wiley. doi: 10.1002/ana.22629.

Magen, S., Magnani, R., Haziza, S., Hershkovitz, E., Houtz, R., Cambi, F., & Parvari, R. (2012). Human Calmodulin Methyltransferase: Expression, Activity on Calmodulin, and Hsp90 Dependence. PLOS ONE, 7(12), e52425.Public Library of Science (PLoS). doi: 10.1371/journal.pone.0052425.

Wang, E., & Cambi, F. (2012). MicroRNA expression in mouse oligodendrocytes and regulation of proteolipid protein gene expression. JOURNAL OF NEUROSCIENCE RESEARCH, 90(9), 1701-1712.Wiley. doi: 10.1002/jnr.23055.

Wang, E., Aslanzadeh, V., Papa, F., Zhu, H., de la Grange, P., & Cambi, F. (2012). Global Profiling of Alternative Splicing Events and Gene Expression Regulated by hnRNPH/F. PLOS ONE, 7(12), e51266.Public Library of Science (PLoS). doi: 10.1371/journal.pone.0051266.

Zhu, H., Zhao, L., Wang, E., Dimova, N., Liu, G., Feng, Y., & Cambi, F. (2012). The QKI-PLP pathway controls SIRT2 abundance in CNS myelin. GLIA, 60(1), 69-82.Wiley. doi: 10.1002/glia.21248.

Tanner, C.M., Kamel, F., Ross, G.W., Hoppin, J.A., Goldman, S.M., Korell, M., Marras, C., Bhudhikanok, G.S., Kasten, M., Chade, A.R., Comyns, K., Richards, M.B., Meng, C., Priestley, B., Fernandez, H.H., Cambi, F., Umbach, D.M., Blair, A., Sandler, D.P., & Langston, J.W. (2011). Rotenone, Paraquat, and Parkinson's Disease. ENVIRONMENTAL HEALTH PERSPECTIVES, 119(6), 866-872.Environmental Health Perspectives. doi: 10.1289/ehp.1002839.

Wang, E., Mueller, W.F., Hertel, K.J., & Cambi, F. (2011). G Run-mediated Recognition of Proteolipid Protein and DM20 5′ Splice Sites by U1 Small Nuclear RNA Is Regulated by Context and Proximity to the Splice Site. JOURNAL OF BIOLOGICAL CHEMISTRY, 286(6), 4059-4071.Elsevier BV. doi: 10.1074/jbc.M110.199927.

Bargagna-Mohan, P., Paranthan, R.R., Hamza, A., Dimova, N., Trucchi, B., Srinivasan, C., Elliott, G.I., Zhan, C.G., Lau, D.L., Zhu, H., Kasahara, K., Inagaki, M., Cambi, F., & Mohan, R. (2010). Withaferin A Targets Intermediate Filaments Glial Fibrillary Acidic Protein and Vimentin in a Model of Retinal Gliosis. JOURNAL OF BIOLOGICAL CHEMISTRY, 285(10), 7657-7669.Elsevier BV. doi: 10.1074/jbc.M109.093765.

Schneider, J.S., Sendek, S., Daskalakis, C., & Cambi, F. (2010). GM1 ganglioside in Parkinson's disease: Results of a five year open study. JOURNAL OF THE NEUROLOGICAL SCIENCES, 292(1-2), 45-51.Elsevier BV. doi: 10.1016/j.jns.2010.02.009.

Wang, E., & Cambi, F. (2009). Heterogeneous Nuclear Ribonucleoproteins H and F Regulate the Proteolipid Protein/DM20 Ratio by Recruiting U1 Small Nuclear Ribonucleoprotein through a Complex Array of G Runs. JOURNAL OF BIOLOGICAL CHEMISTRY, 284(17), 11194-11204.Elsevier BV. doi: 10.1074/jbc.M809373200.

DeStefano, A.L., Latourelle, J., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Watts, R., Guttman, M., Racette, B.A., Perlmutter, J.S., Marlor, L., Shill, H., Singer, C., Goldwurm, S., Pezzoli, G., Saint-Hilaire, M.H., Hendricks, A.E., Gower, A., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Huskey, K.W., Baker, K.B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Al-hinti, J., Moller, A.T., Ostergaard, K., Sherman, S.J., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). Replication of association between ELAVL4 and Parkinson disease:: the GenePD study. HUMAN GENETICS, 124(1), 95-99.Springer Science and Business Media LLC. doi: 10.1007/s00439-008-0526-4.

Latourelle, J.C., Sun, M., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Watts, R.L., Guttman, M., Racette, B.A., Perlmutter, J.S., Ahmed, A., Shill, H.A., Singer, C., Goldwurm, S., Pezzoli, G., Zini, M., Saint-Hilaire, M.H., Hendricks, A.E., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Huskey, K.W., Laramie, J.M., DeStefano, A.L., Baker, K.B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Al-hinti, J., Moller, A.T., Ostergaard, K., Sherman, S.J., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC MEDICINE, 6(1), 32.Springer Science and Business Media LLC. doi: 10.1186/1741-7015-6-32.

McNicoll, C.F., Latourelle, J.C., MacDonald, M.E., Lew, M.F., Suchowersky, O., Klein, C., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Watts, R.L., Guttman, M., Racette, B.A., Perlmutter, J.S., Ahmed, A., Shill, H.A., Singer, C., Saint-Hilaire, M.H., Massood, T., Huskey, K.W., DeStefano, A.L., Gillis, T., Mysore, J., Goldwurm, S., Pezzoli, G., Baker, K.B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Al-Hinti, J., Moller, A.T., Ostergaard, K., Sherman, S.J., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). Huntington CAG repeat size does not modify onset age in familial Parkinson's disease:: The GenePD study. MOVEMENT DISORDERS, 23(11), 1596-1601.Wiley. doi: 10.1002/mds.22186.

Tobin, J.E., Latourelle, J.C., Lew, M.F., Klein, C., Suchowersky, O., Shill, H.A., Golbe, L.I., Mark, M.H., Growdon, J.H., Wooten, G.F., Racette, B.A., Perlmutter, J.S., Watts, R., Guttman, M., Baker, K.B., Goldwurm, S., Pezzoli, G., Singer, C., Saint-Hilaire, M.H., Hendricks, A.E., Williamson, S., Nagle, M.W., Wilk, J.B., Massood, T., Laramie, J.M., DeStefano, A.L., Litvan, I., Nicholson, G., Corbett, A., Isaacson, S., Burn, D.J., Chinnery, P.F., Pramstaller, P.P., Sherman, S., Al-Hinti, J., Drasby, E., Nance, M., Moller, A.T., Ostergaard, K., Roxburgh, R., Snow, B., Slevin, J.T., Cambi, F., Gusella, J.F., & Myers, R.H. (2008). Haplotypes and gene expression implicate the MAPT region for Parkinson disease -: The GenePD Study. NEUROLOGY, 71(1), 28-34.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/01.wnl.0000304051.01650.23.

Wang, E., Dimova, N., Sperle, K., Huang, Z., Lock, L., McCulloch, M.C., Edgar, J.M., Hobson, G.M., & Cambi, F. (2008). Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability. EXPERIMENTAL NEUROLOGY, 214(2), 322-330.Elsevier BV. doi: 10.1016/j.expneurol.2008.09.001.

Squillaro, T., Cambi, F., Ciacci, G., Rossi, S., Ulivelli, M., Malandrini, A., Mencarelli, M.A., Mari, F., Renieri, A., & Ariani, F. (2007). Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease. JOURNAL OF HUMAN GENETICS, 52(3), 201-204.Springer Science and Business Media LLC. doi: 10.1007/s10038-006-0105-2.

Wang, E., Dimova, N., & Cambi, F. (2007). PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. NUCLEIC ACIDS RESEARCH, 35(12), 4164-4178.Oxford University Press (OUP). doi: 10.1093/nar/gkm387.

Hobson, G.M., Huang, Z., Sperle, K., Sistermans, E., Rogan, P.K., Garbern, J.Y., Kolodny, E., Naidu, S., & Cambi, F. (2006). Splice-site contribution in alternative splicing of PLP1 and DM20:: Molecular studies in oligodendrocytes. HUMAN MUTATION, 27(1), 69-77.Hindawi Limited. doi: 10.1002/humu.20276.

Sabet, A., Li, J., Ghandour, K., Pu, Q., Wu, X., Kamholz, J., Shy, M.E., & Cambi, F. (2006). Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie- Tooth neuropathy 1B. NEUROLOGY, 67(7), 1141-1146.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/01.wnl.0000238499.37764.b1.

Wang, E.M., Huang, Z., Hobson, G.M., Dimova, N., Sperle, K., McCullough, A., & Cambi, F. (2006). PLP1 alternative splicing in differentiating oligodendrocytes: Characterization of an exonic splicing enhancer. JOURNAL OF CELLULAR BIOCHEMISTRY, 97(5), 999-1016.Wiley. doi: 10.1002/jcb.20692.

Wilk, J.B., Tobin, J.E., Suchowersky, O., Shill, H.A., Klein, C., Wooten, G.F., Lew, M.F., Mark, M.H., Guttman, M., Watts, R.L., Singer, C., Growdon, J.H., Latourelle, J.C., Saint-Hilaire, M.H., DeStefano, A.L., Prakash, R., Williamson, S., Berg, C.J., Sun, M., Goldwurm, S., Pezzoli, G., Racette, B.A., Perlmutter, J.S., Parsian, A., Baker, K.B., Giroux, M.L., Litvan, I., Pramstaller, P.P., Nicholson, G., Burn, D.J., Chinnery, P.F., Vieregge, P., Slevin, J.T., Cambi, F., MacDonald, M.E., Gusella, J.F., Myers, R.H., & Golbe, L.I. (2006). Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age -: The GenePD study. NEUROLOGY, 67(12), 2206-2210.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/01.wnl.0000249149.22407.d1.

Mari, F., Kilstrup-Nielsen, C., Cambi, F., Speciale, C., Mencarelli, M.A., & Renieri, A. (2005). Genetics and mechanisms of disease in Rett syndrome. Drug Discovery Today: Disease Mechanisms, 2(4), 419-425.Elsevier BV. doi: 10.1016/j.ddmec.2005.11.001.

Garbern, J., Shy, M., Krajewski, K., Kamholz, J., Hobson, G., & Cambi, F. (2001). Evidence for neuroaxonal injury in patients with proteolipid gene mutations. NEUROLOGY, 57(10), 1938-1939.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.57.10.1938-a.

Mars, T., Yu, K.J., Tang, X.M., Miranda, A.F., Grubic, Z., Cambi, F., & King, M.P. (2001). Differentiation of glial cells and motor neurons during the formation of neuromuscular junctions in cocultures of rat spinal cord explant and human muscle. JOURNAL OF COMPARATIVE NEUROLOGY, 438(2), 239-251.Wiley. doi: 10.1002/cne.1312.

Awatramani, R., Beesley, J., Yang, H., Jiang, H., Cambi, F., Grinspan, J., Garbern, J., & Kamholz, J. (2000). Gtx, an oligondendrocyte-specific homeodomain protein, has repressor activity. Journal of Neuroscience Research, 61(4), 376-387. doi: 10.1002/1097-4547(20000815)61:4<376::aid-jnr4>3.0.co;2-%23.

Awatramani, R., Beesley, J., Yang, H.B., Jiang, H.Y., Cambi, F., Grinspan, J., Garbern, J., & Kamholz, J. (2000). Gtx, an oligodendrocyte-specific homeodomain protein, has repressor activity. JOURNAL OF NEUROSCIENCE RESEARCH, 61(4), 376-387.Wiley. doi: 10.1002/1097-4547(20000815)61:4<376::AID-JNR4>3.0.CO;2-#.

Hentati, A., Deng, H.X., Zhai, H., Chen, W., Yang, Y., Hung, W.Y., Azim, A.C., Bohlega, S., Tandan, R., Warner, C., Laing, N.G., Cambi, F., Mitsumoto, H., Roos, R.P., Boustany, R.M., Ben Hamida, M., Hentati, F., & Siddique, T. (2000). Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. NEUROLOGY, 55(9), 1388-1390.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.55.9.1388.

Tang, X.M., Beesley, J.S., Grinspan, J.B., Seth, P., Kamholz, J., & Cambi, F. (2000). Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. JOURNAL OF CELLULAR BIOCHEMISTRY, 76(2), 270-279.Wiley. doi: 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6.

Tang, X.M., Beesley, J.S., Grinspan, J.B., Seth, P., Kamholz, J., & Cambi, F. (2000). Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. Journal of Cellular Biochemistry, 76(2), 270-279. doi: 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6.

Garbern, J., Cambi, F., Shy, M., & Kamholz, J. (1999). The molecular pathogenesis of Pelizaeus-Merzbacher disease. ARCHIVES OF NEUROLOGY, 56(10), 1210-1214.American Medical Association (AMA). doi: 10.1001/archneur.56.10.1210.

Garbern, J.Y., Cambi, F., Lewis, R., Shy, M., Sima, A., Kraft, G., Vallat, J.M., Bosch, E.P., Hodes, M.E., Dlouhy, S., Raskind, W., Bird, T., Macklin, W., & Kamholz, J. (1999). Peripheral neuropathy caused by proteolipid protein gene mutations. CHARCOT-MARIE-TOOTH DISORDERS, 883(1), 351-365.Wiley. doi: 10.1111/j.1749-6632.1999.tb08597.x.

Tang, X.M., Strocchi, P., & Cambi, F. (1998). Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. JOURNAL OF CELLULAR BIOCHEMISTRY, 68(1), 128-137.Wiley. doi: 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D.

Tang, X.M., Strocchi, P., & Cambi, F. (1998). Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. Journal of Cellular Biochemistry, 68(1), 128-137. doi: 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D.

Berghella, V., Steele, D., Spector, T., Cambi, F., & Johnson, A. (1997). Successful pregnancy in a neurologically impaired woman with Wilson's disease. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 176(3), 712-714.Elsevier BV. doi: 10.1016/S0002-9378(97)70577-5.

Garbern, J.Y., Cambi, F., Tang, X.M., Sima, A.A.F., Vallat, J.M., Bosch, E.P., Lewis, R., Shy, M., Sohi, J., Kraft, G., Chen, K.L., Joshi, I., Leonard, D.G.B., Johnson, W., Raskind, W., Dlouhy, S.R., Pratt, V., Hodes, M.E., Bird, T., & Kamholz, J. (1997). Proteolipid protein is necessary in peripheral as well as central myelin. NEURON, 19(1), 205-218.Elsevier BV. doi: 10.1016/S0896-6273(00)80360-8.

Cambi, F., Tang, X.M., Cordray, P., Fain, P.R., Keppen, L.D., & Barker, D.F. (1996). Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. NEUROLOGY, 46(4), 1112-1117.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.46.4.1112.

Fink, J.K., HeimanPatterson, T., Bird, T., Cambi, F., Dube, M.P., Figlewicz, D.A.Fink, J.K., Haines, J.L., HeimanPatterson, T., Hentati, A., PericakVance, M.A., Raskind, W., Rouleau, G.A., & Siddique, T. (1996). Hereditary spastic paraplegia: Advances in genetic research. NEUROLOGY, 46(6), 1507-1514.Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/WNL.46.6.1507.

Fink, J.K., Heiman-Patterson, T., Bird, T., Cambi, F., Dubé, M.P., Figlewicz, D.A.Fink, J.K., Haines, J.L., Heiman-Patterson, T., Hentati, A., Pericak-Vance, M.A., Raskind, W., Rouleau, G.A., & Siddique, T. (1996). Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology, 46(6), 1507-1514. doi: 10.1212/wnl.46.6.1507.

CAMBI, F., TARTAGLINO, L., LUBLIN, F., & MCCARREN, D. (1995). X-LINKED PURE FAMILIAL SPASTIC PARAPARESIS - CHARACTERIZATION OF A LARGE KINDRED WITH MAGNETIC-RESONANCE-IMAGING STUDIES. ARCHIVES OF NEUROLOGY, 52(7), 665-669.American Medical Association (AMA). doi: 10.1001/archneur.1995.00540310035013.

STROCCHI, P., TANG, X.M., & CAMBI, F. (1995). MOLECULAR DIAGNOSIS OF TRANSTHYRETIN MET(30) MUTATION IN AN ITALIAN FAMILY WITH FAMILIAL AMYLOIDOTIC POLYNEUROPATHY. FEBS LETTERS, 359(2-3), 203-205.Wiley. doi: 10.1016/0014-5793(95)00046-C.